Wall Street is neutral on Cross Country Healthcare, Inc. (CCRN). On average, analysts give Cross Country Healthcare, Inc. a Buy rating. The average price target is $8.5, which means analysts expect the stock to climb by 39.12% over the next twelve months.
That average ranking earns Cross Country Healthcare, Inc. an Analyst Rating of 18, which is better than 18% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Cross Country Healthcare, Inc. Stock Today?
Cross Country Healthcare, Inc. (CCRN) stock has risen 5.71% while the S&P 500 is flat 0% as of 11:33 AM on Friday, Sep 25. CCRN is higher by $0.33 from the previous closing price of $5.78 on volume of 81,972 shares. Over the past year the S&P 500 has risen 9.03% while CCRN has fallen -41.70%. CCRN lost -$0.57 per share the over the last 12 months.
Click Here to get the full report on Cross Country Healthcare, Inc. (CCRN) Stock.